Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

Amgen Announces Webcast of 2012 Third Quarter Financial Results



       Amgen Announces Webcast of 2012 Third Quarter Financial Results

PR Newswire

THOUSAND OAKS, Calif., Oct. 18, 2012

THOUSAND OAKS, Calif., Oct. 18, 2012 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today
announced that it will report its third quarter financial results on Tuesday,
Oct. 23, 2012, after the close of the U.S. financial markets. The announcement
will be followed by a conference call with the investment community at 2:15
p.m. Pacific Daylight Time.  Participating in the call from Amgen will be
Robert A. Bradway, president & CEO, and other members of Amgen's senior
management team.

Live audio of the conference call will be simultaneously broadcast over the
Internet and will be available to members of the news media, investors and the
general public.

The webcast of the conference, as with other selected presentations regarding
developments in Amgen's business given by management at certain investor and
medical conferences, can be found on Amgen's website, www.amgen.com, under
Investors. Information regarding presentation times, webcast availability and
webcast links are noted on Amgen's Investor Relations Events Calendar. The
webcast will be archived and available for replay for at least 30 days after
the event.

About Amgen
Amgen discovers, develops, manufactures and delivers innovative human
therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first
companies to realize the new science's promise by bringing safe, effective
medicines from lab to manufacturing plant to patient. Amgen therapeutics have
changed the practice of medicine, helping millions of people around the world
in the fight against cancer, kidney disease, rheumatoid arthritis, bone
disease and other serious illnesses. With a deep and broad pipeline of
potential new medicines, Amgen remains committed to advancing science to
dramatically improve people's lives. To learn more about our pioneering
science and vital medicines, visit www.amgen.com.  Follow us on
www.twitter.com/amgen.

CONTACT: Amgen, Thousand Oaks
Christine Regan, 805-447-5476 (media)
Arvind Sood, 805-447-1060 (investors)

(Logo: http://photos.prnewswire.com/prnh/20081015/AMGENLOGO)

 

SOURCE Amgen

Website: http://www.amgen.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement